Valuation: OneSource Specialty Pharma Limited

Market Cap 185B 1.97B 1.79B 1.65B 1.49B 2.82B 2.92B 19.88B 7.88B 99.24B 7.39B 7.23B 314B P/E 2027 *
40.5x
P/E 2028 * 21.6x
Enterprise Value 194B 2.06B 1.88B 1.73B 1.56B 2.95B 3.06B 20.83B 8.25B 104B 7.74B 7.58B 329B EV / Sales 2027 *
8.21x
EV / Sales 2028 * 5.42x
Free-Float
64.51%
Yield 2027 *
-
Yield 2028 * -
1 day+0.16%
1 week-1.22%
Current month+3.18%
1 month+12.52%
3 months+3.43%
6 months-12.10%
Current year-10.93%
1 week 1,576.5
Extreme 1576.5
1,688
1 month 1,320.6
Extreme 1320.6
1,688
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,917.8
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-29
Director of Finance/CFO - 2024-07-03
Compliance Officer - 2023-03-13
Director TitleAgeSince
Chairman 65 2025-09-21
Director/Board Member 54 2024-02-29
Director/Board Member 66 2025-02-26
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%-1.22%-6.89% - 1.96B
-1.29%-1.76%+51.98%+64.66% 66.33B
-0.09%+7.58%+12.54%+93.05% 60.62B
+0.63%+1.64%+24.25%+89.70% 55.5B
-1.26%-1.45%+9.20%+117.42% 47.58B
-0.15%-5.06%+22.49%+29.27% 43.69B
-3.15%-16.63%+141.35%+685.27% 37.27B
+0.23%+1.66%+14.85%+49.06% 36.57B
+2.35%-3.61%+78.64%+60.70% 32.22B
+1.42%+5.84%-37.75%+402.78% 26.58B
Average -0.09%+0.36%+31.07%+176.88% 41B
Weighted average by Cap. -0.27%+0.33%+35.03%+152.00%

Financials

2027 *2028 *
Net sales 23.61B 251M 228M 211M 191M 360M 372M 2.54B 1.01B 12.67B 943M 923M 40.13B 34.36B 366M 332M 307M 277M 524M 542M 3.69B 1.46B 18.44B 1.37B 1.34B 58.41B
Net income 4.35B 46.3M 42.06M 38.86M 35.1M 66.25M 68.58M 467M 185M 2.33B 174M 170M 7.39B 8.83B 94.03M 85.43M 78.93M 71.29M 135M 139M 949M 376M 4.74B 353M 345M 15.01B
Net Debt 8.86B 94.32M 85.69M 79.17M 71.51M 135M 140M 952M 377M 4.75B 354M 346M 15.05B 1.16B 12.4M 11.26M 10.41M 9.4M 17.74M 18.36M 125M 49.58M 625M 46.52M 45.53M 1.98B
Projected Income Statement - Annual - OneSource Specialty Pharma Limited
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based Contract Development and Manufacturing Organization (CDMO). The Company offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply. The Company focuses on the development and manufacturing of complex pharmaceutical products including biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatine capsules). It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. Its integrated services offer comprehensive biologics solutions. The Company develops a variety of soft gelatin capsules including traditional and enteric softgels, vegan capsule alternatives, chewable formats and specialty dosage forms, and liposomal systems and applicaps. It also provides end-to-end development and manufacturing of sterile injectable products.
Employees
1,674
Date Price Change Volume
26-11-16 ₹1,612.70 +0.16% 311,345
26-11-13 ₹1,610.10 -0.61% 599,203
26-11-12 ₹1,620.00 +2.42% 277,501
26-11-11 ₹1,581.70 -2.24% 221,763
26-11-09 ₹1,618.00 -0.89% 165,587
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - OneSource Specialty Pharma Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,612.70INR
Average target price
2,078.25INR
Spread / Average Target
+28.87%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OneSource Specialty Pharma Limited
  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock